RARE DISEASERESEARCH ATLAS
Open navigation menu

ORPHA:213802

Rhabdomyosarcoma of the cervix uteri

high confidenceDisorder

Also known as: Cervical rhabdomyosarcoma

Query health: suspect — Only one of 2 strategies returned hits (phrase).

Publications

341

74.5th percentile

Trials

0

Interventional, condition-specific

Researchers

1,100

Distinct authors in sample

Gene link

—

Readiness

2/6

Stages with a signal

Clinical definition (Orphanet)

Rhabdomyosarcoma of the cervix uteri is a rare, highly malignant soft tissue sarcoma located in the uterine cervix and arising from primitive mesenchymal cells displaying skeletal muscle differentiation. It most often presents with abnormal vaginal discharge or dysfunctional uterine bleeding, abdominal pain and/or a cervical mass protruding into the vagina. Association with DICER1 syndrome has been reported.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (4)

cervical rhabdomyosarcoma · rhabdomyosarcoma (disease) of uterine cervix · uterine cervix rhabdomyosarcoma · uterine cervix rhabdomyosarcoma (disease)

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

2/6 stages with a signal

No specific-condition interventional trial, but broader-category trials exist — discuss eligibility with a clinician.

  1. Gene identifiedNot found

    No GenCC disease–gene assertion in this build

  2. LiteraturePresent

    341 matched papers (156 in last 10 years) Source

  3. Phenotype characterisedNot checked

    Not yet enriched from Monarch / HPO

  4. Animal modelNot checked

    Not yet enriched from Monarch / Alliance

  5. Orphan designationNot checked

    FDA/EMA orphan-drug designation not enriched yet

  6. Interventional trialPartial

    None under the specific name; 212 for broader category rhabdomyosarcoma

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Not yet — the cause hasn't been pinned down in GenCC.

No strong gene–disease assertion joined for this Orphanet entity.

Phenotypes (Monarch / HPO)

Not enriched in this build — Monarch phenotype joins were not run for this record.

Animal models (Monarch / Alliance)

Not enriched in this build.

Literature

Is anyone studying this?

341

341 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.

341 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).

156 in the last 10 years · high confidence · 74.5th percentile (publications denominator)

Phrase hits: 341 · MeSH hits: 0

Open Europe PMC search

Who's working on it?

1,100

Distinct author names in 200 sampled papers — named people below.

Who's working on it?

No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.

  1. 01
    Schultz KAP4 papers · 2024

    International Pleuropulmonary Blastoma (PPB)/DICER1 Registry, Children's Minnesota, Minneapolis, MN, USA.

    Papers in Europe PMC
  2. 02
    Dehner LP3 papers · 2024

    Lauren V. Ackerman Laboratory of Surgical Pathology, Washington University Medical Center, St. Louis, MO, USA.

    Papers in Europe PMC
  3. 03
    Hill DA3 papers · 2024

    Division of Pathology and Center for Cancer and Immunology Research, Children's National Health System, Washington, DC, USA.

    Papers in Europe PMC
  4. 04
    Soslow RA3 papers · 2023

    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

    Papers in Europe PMC
  5. 05
    Stewart DR3 papers · 2024

    Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.

    Papers in Europe PMC
  6. 06
    Tonni G3 papers · 2024

    Division of Obstetrics and Gynecology, Guastalla Civil Hospital, AUSL Reggio Emilia, Guastalla, Italy. Tonni.Gabriele@ausl.re.it

    Papers in Europe PMC
  7. 07
    Zheng W3 papers · 2024

    Department of Radiology, Women's Hospital, Zhejiang University School of Medicine, Xueshi Rd No. 1, Hangzhou, Zhejiang, People's Republic of China.

    Papers in Europe PMC
  8. 08
    AlMulai I2 papers · 2025

    Obstetrics and Gynaecology, Latifa Hospital, Dubai Health, Dubai, ARE.

    Papers in Europe PMC
  9. 09
    Antiñolo G2 papers · 2020

    Department of Materno-Fetal Medicine, Genetics, and Reproduction, Institute of Biomedicine of Seville (IBIS), Hospital Universitario Virgen del Rocio/CSIC/University of Seville, Avda. Manuel Siurot s/n ES-41013, Seville, Spain. gantinolo@us.es.

    Papers in Europe PMC
  10. 10
    Campisi P2 papers · 2022

    Department of Otolaryngology-Head and Neck Surgery, Hospital for Sick Children, University of Toronto, Toronto ON.

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

0

interventional trials for this specific condition

No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present). 212 trials are registered for rhabdomyosarcoma, the broader category — shown separately because they may or may not enrol this specific subtype.

Data as of 27 July 2026

No matched interventional trials. This is true for 73% of diseases in the trials denominator (5114 of 7003). Here are the researchers publishing on it.

high confidence · 36.5th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.

212 interventional trials matched rhabdomyosarcoma, the broader category — listed below. Those studies are not counted in the condition-specific total.

Broader category: rhabdomyosarcoma

212

Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.

Worth raising with a clinician. How we count trials.

Recruiting under the broader category

Where to find support

We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

"Rhabdomyosarcoma of the cervix uteri" OR "Rhabdomyosarcoma of cervix uteri" OR "Cervical rhabdomyosarcoma" OR "rhabdomyosarcoma (disease) of uterine cervix" OR "rhabdomyosarcoma (disease) of the uterine cervix" OR "uterine cervix rhabdomyosarcoma" OR "uterine cervix rhabdomyosarcoma (disease)"

Run this search on Europe PMC

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Rhabdomyosarcoma of the cervix uteri" OR "Rhabdomyosarcoma of cervix uteri" OR "Cervical rhabdomyosarcoma" OR "rhabdomyosarcoma (disease) of uterine cervix" OR "rhabdomyosarcoma (disease) of the uterine cervix" OR "uterine cervix rhabdomyosarcoma" OR "uterine cervix rhabdomyosarcoma (disease)" OR "sarcoma of cervix uteri"

Recall-expansion terms: sarcoma of cervix uteri

Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.

Parent-category trials query:

"rhabdomyosarcoma"

Query health: suspect — strategies attempted: phrase, recall-expansion; with hits: phrase

Run this search on ClinicalTrials.gov

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • No synonyms dropped by stoplist
  • No label/synonym collisions with other diseases in this corpus

Ingested 2026-07-27T09:39:25.742Z